29.99
price up icon3.41%   0.99
after-market 시간 외 거래: 29.99
loading

Surmodics Inc 주식(SRDX)의 최신 뉴스

pulisher
Jun 08, 2025

Surmodics, Inc. (NASDAQ:SRDX) Shares Bought by Bank of America Corp DE - Defense World

Jun 08, 2025
pulisher
May 30, 2025

Why Is SurModics (SRDX) Up 6% Since Last Earnings Report? - sharewise

May 30, 2025
pulisher
May 24, 2025

Surmodics, Inc. (NASDAQ:SRDX) Shares Bought by Deutsche Bank AG - Defense World

May 24, 2025
pulisher
May 23, 2025

Surmodics, Inc. (SRDX) Stock Analysis: Exploring a 47.46% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews

May 23, 2025
pulisher
May 15, 2025

US FTC files amended complaint to block GTCR acquisition of Surmodics - MLex

May 15, 2025
pulisher
May 13, 2025

Surmodics Shares Positive TRANSCEND Trial Results - Medical Product Outsourcing

May 13, 2025
pulisher
May 08, 2025

Illinois and Minnesota AGs Join FTC’s Lawsuit Against Private Equity Firm - regulatoryoversight.com

May 08, 2025
pulisher
May 05, 2025

Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results - ADVFN

May 05, 2025
pulisher
May 04, 2025

Equities Analysts Issue Forecasts for Surmodics Q2 Earnings - Defense World

May 04, 2025
pulisher
May 03, 2025

Legal & General Group Plc Buys 880 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World

May 03, 2025
pulisher
May 03, 2025

Zacks Research Weighs in on Surmodics FY2025 Earnings - Defense World

May 03, 2025
pulisher
May 02, 2025

Are Options Traders Betting on a Big Move in Surmodics Stock? - Yahoo Finance

May 02, 2025
pulisher
May 01, 2025

SRDX Stock Down Following Q2 Earnings Miss, Gross Margin Contracts - TradingView

May 01, 2025
pulisher
May 01, 2025

SurModics: Fiscal Q2 Earnings Snapshot - New Haven Register

May 01, 2025
pulisher
May 01, 2025

Surmodics Reports Q2 2025 Results Amid Acquisition Challenges - TipRanks

May 01, 2025
pulisher
Apr 30, 2025

SurModics (SRDX) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

SurModics stock touches 52-week low at $26.21 amid market shifts - Investing.com

Apr 30, 2025
pulisher
Apr 30, 2025

Surmodics (SRDX) Projects Declining Revenue for Fiscal 2025 | SR - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance - BioSpace

Apr 30, 2025
pulisher
Apr 30, 2025

Surmodics (SRDX) Projects Declining Revenue for Fiscal 2025 | SRDX Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Surmodics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Apr 30, 2025
pulisher
Apr 30, 2025

SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

Surmodics (SRDX) Reports Lower Than Expected Q2 Revenue Amid Ant - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial R - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

SURMODICS INC SEC 10-Q Report - TradingView

Apr 30, 2025
pulisher
Apr 30, 2025

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance | SRDX Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Surmodics Reports Second Quarter Fiscal 2025 Financial Results - TradingView

Apr 30, 2025
pulisher
Apr 29, 2025

A Look at Surmodics's Upcoming Earnings Report - Nasdaq

Apr 29, 2025
pulisher
Apr 29, 2025

How To Trade (SRDX) - news.stocktradersdaily.com

Apr 29, 2025
pulisher
Apr 28, 2025

Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30 - 01net

Apr 28, 2025
pulisher
Apr 28, 2025

Surmodics to Report Second Quarter of Fiscal 2025 Financial Resu - GuruFocus

Apr 28, 2025
pulisher
Apr 26, 2025

FTC Expands Lawsuit Against GTCR Over Surmodics Acquisition - MSN

Apr 26, 2025
pulisher
Apr 22, 2025

Surmodics' SurVeil DCB Matches IN.PACT Admiral In Efficacy With Lower Drug Dose In Global Trial - Nasdaq

Apr 22, 2025
pulisher
Apr 22, 2025

Surmodics (SRDX) Publishes Promising Clinical Trial Results for SurVeil DCB | SRDX Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Surmodics Announces Publication of TRANSCEND Trial, Highlighting - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon - Business Wire

Apr 22, 2025
pulisher
Apr 21, 2025

Attorney General Ellison sues to block harmful private-equity acquisition of Minnesota medical-device coating company - Red Lake Nation News

Apr 21, 2025
pulisher
Apr 18, 2025

Illinois, Minnesota join FTC challenge against $627M Surmodics buyout - MedTech Dive

Apr 18, 2025
pulisher
Apr 18, 2025

Minnesota AG Ellison joins federal lawsuit to stop merger of companies that make medical device coatings - KIMT

Apr 18, 2025
pulisher
Apr 17, 2025

Illinois joins FTC suit to block GTCR’s takeover of Surmodics - Crain's Chicago Business

Apr 17, 2025
pulisher
Apr 17, 2025

AG Ellison Joins Suit to Block Surmodics Acquisition - Twin Cities Business

Apr 17, 2025
pulisher
Apr 12, 2025

Corebridge Financial Inc. Lowers Stock Position in Surmodics, Inc. (NASDAQ:SRDX) - Defense World

Apr 12, 2025
pulisher
Apr 08, 2025

(SRDX) Long Term Investment Analysis - news.stocktradersdaily.com

Apr 08, 2025
pulisher
Apr 07, 2025

Surmodics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

Apr 07, 2025
$301.05
price down icon 0.19%
medical_devices PHG
$24.17
price down icon 1.43%
medical_devices STE
$237.55
price down icon 0.29%
$82.93
price down icon 0.78%
$76.07
price down icon 0.07%
medical_devices EW
$76.79
price down icon 0.30%
자본화:     |  볼륨(24시간):